$LLYX

        • URAX Daily Target 2X Long Uranium ETF

          LLYX Daily Target 2X Long LLY ETF

          MSTX Daily Target 1.75X Long MSTR ETF

          SMST Daily Target 1.5X Short MSTR ETF

          SMCX Daily Target 2X Long MSCI ETF

          AVGX Daily Target 2X Long AVGO ETF

          QQQY Nasdaq 100 Enhanced Options Income ETF

          JEPY S&P 500 Enhanced Options Income ETF

          IWMY R2000 Enhanced Options Income ETF

          SPYT S&P 500 Income Target ETF

          USOY Oil Enhanced Options Income ETF

          QQQT NASDAQ 100 Income Target ETF

          QTUM Quantum ETF

          SIXG Connective Technologies ETF

          HDRO Next Gen H2 ETF

          CRUZ Hotel, Airline, and Cruise ETF

          Product Guide Materials
  • About us
  • Insights
  • News
  • Contact Us

LLYX

$

Defiance Daily Target 2X Long LLY ETF

Name(Required)
This field is for validation purposes and should be left unchanged.
Distribution Rate *
-%
As of —
Distribution Frequency
Monthly
30-Day SEC Yield **
-%
As of —
rating

Defiance Daily Target 2X Long LLY ETF

The Defiance Daily Target 2X Long LLY ETF (the “Fund”) seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of Eli Lilly and Company (NYSE: LLY”) (the “Underlying Security” or “LLY”). LLYX does not invest directly in LLY. Because the Fund seeks daily leveraged investment results, it is very different from most other exchange-traded funds. It is also riskier than alternatives that do not use leverage. There is no guarantee that the Fund will meet its stated objective. The fund should not be expected to provide 2 times the cumulative return of LLY for periods greater than a day.

Underlying Stock: Eli Lilly and Company (“LLY”)

LLY is a global pharmaceutical company, which is dedicated to discovering, developing, manufacturing, and marketing innovative medicines in various therapeutic areas, including neuroscience, endocrinology, oncology, cardiovascular diseases, and immunology. LLY’s portfolio encompasses a wide range of prescription drugs, biologics, and animal health products. LLY is listed on the New York Stock Exchange (“NYSE”).

Fund Details

 Data as of 09/18/2024
Net Assets $3.99M
Premium/discount 0.55%
NAV $26.57
Closing Price $26.72
Shares Outstanding 150,000
Median 30 Day Spread 0.49%
Fund inception 08/07/2024
Ticker LLYX
Primary Exchange NYSE
CUSIP 88636J261
Fund Holdings 4
NAV Symbol LLYX.NV
Expense Ratio 1.29%
30 Day SEC Yield* —
* Yield as of —

LLYXMarket Price

Performance

YTD 1 Month 3 Months 6 Months 1 Year 3 Years 5 Years Since Inception
Total Return NAV (%) xx.xx% xx.xx% xx.xx% xx.xx% xx.xx% xx.xx% xx.xx% 51.21%
Market Price (%) xx.xx% xx.xx% xx.xx% xx.xx% xx.xx% xx.xx% xx.xx% 51.32%
1 Year Since Inception
Total Return (%) xx.xx% xx.xx%
Market Price (%) xx.xx% xx.xx%
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. Performance current to the most recent month-end can be obtained by calling 833.333.9383. Short term performance, in particular, is not a good indication of the fund’s future performance, and an investment should not be made based solely on returns. Market price is the price at which shares in the ETF can be brought or sold on the exchanges during trading hours, while the net asset value (NAV) represents the value of each share’s portion of the fund’s underlying assets and cash at the end of the trading day.

Top Holdings

View full holdings
Name Symbol Stock price % Net assets Shares Held Market Value
Eli Lilly & Co Swap Cantor – L 532457108 TRS 090825 $915.04 193.83% 11,488 $10,511,980
First American Government Obligations Fund 12/01/2031 FGXXX $100.00 6.71% 364,025 $364,025
Eli Lilly & Co LLY $915.04 6.36% 377 $344,970
Cash & Other Cash&Other $1.00 -106.90% -5,797,671 $-5,797,671
Data as of 09/20/2024. Fund holdings are subject to change at any time and should not be considered recommendations to buy or sell any security.
View full holdings
Download Fund Documents
Prospectus
Summary Prospectus
SAI

Distribution

Declaration Date Ex-Div Date Record Date Payable Date Amount ($)
9/30/2024 10/1/2024 10/1/2024 10/3/2024 $x
10/31/2024 11/1/2024 11/1/2024 11/4/2024 $x
11/29/2024 12/2/2024 12/2/2024 12/4/2024 $x
12/30/2024 12/31/2024 12/31/2024 1/5/2025 $x
Distribution Rate *
As of —		 -%
Distribution Frequency Monthly
30-Day SEC Yield **
As of —		 -%